News summary

A glucose-powered artificial neuroimmune axis for metabolic control

Source: Nature - Main • Published: 18 Nov 2026, 00:00

Summarized by Masters of Longevity from Nature - Main.

An implantable NeuroAxis used glucose power to normalize glycaemia in diabetic rats.

A glucose-powered artificial neuroimmune axis for metabolic control
Key Takeaways
  • The device is powered solely by endogenous glucose in rats.
  • Closed-loop neuromodulation restored glucose tolerance and insulin sensitivity.
  • Evidence was in rat models and is not proof in humans.
Read the full article at Nature - Main ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.